89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 69 filers reported holding 89BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $502,788 | -96.7% | 32,564 | -96.0% | 0.00% | -100.0% |
| Q2 2023 | $15,237,619 | +11758.4% | 804,096 | +9430.6% | 0.01% | – |
| Q1 2023 | $128,496 | +19.6% | 8,437 | 0.0% | 0.00% | – |
| Q4 2022 | $107,403 | +119.2% | 8,437 | 0.0% | 0.00% | – |
| Q3 2022 | $49,000 | -67.8% | 8,437 | -82.2% | 0.00% | – |
| Q2 2022 | $152,000 | +192.3% | 47,375 | +245.8% | 0.00% | – |
| Q1 2022 | $52,000 | -72.2% | 13,700 | -4.5% | 0.00% | – |
| Q4 2021 | $187,000 | -86.8% | 14,340 | -80.2% | 0.00% | -100.0% |
| Q3 2021 | $1,417,000 | +4.5% | 72,344 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $1,356,000 | -20.8% | 72,525 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $1,712,000 | -3.5% | 72,278 | -0.7% | 0.00% | 0.0% |
| Q4 2020 | $1,774,000 | +1893.3% | 72,782 | +2012.7% | 0.00% | – |
| Q3 2020 | $89,000 | +196.7% | 3,445 | +128.9% | 0.00% | – |
| Q2 2020 | $30,000 | +7.1% | 1,505 | +36.2% | 0.00% | – |
| Q1 2020 | $28,000 | +12.0% | 1,105 | +12.3% | 0.00% | – |
| Q4 2019 | $25,000 | – | 984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
| Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
| Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
| Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
| Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
| Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
| Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
| Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |